• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Is your company still on...


<



Actually to be more specific upper management is on crack with their ridiculous insane unrealistic metrics. They have lost the definition of SALES. it is an utter joke out here.
 












That's the 2nd problem. You stand up and tell them the reality, they don't listen and Guess what your out. It is extremly painful . Looking but not much where I'm at.